NIPT for common aneuploidies (including sex chromosomes)
NIPT for common aneuploidies (including sex chromosomes) (plasma).
NIPT for fetal sexing (X-linked disorders)
NIPT for fetal sexing (X-linked disorders) (plasma).
Pharmacogenetics (DPYD / UGT1A1 only)
DPYD and/or UGT1A1 pharmacogenetic testing for drug response and efficacy (Germline DNA).
Pharmacogenetics (panel testing)
Pharmacogenetic panel testing of markers for drug response and efficacy (Germline DNA).
cfDNA Extraction from Plasma (Round 1)
EQA for quality and quantity of cfDNA extracted from plasma. There are two rounds of EQA per year which need to be purchased separately. This EQA will be distributed in March 2026.
cfDNA Extraction from Plasma (Round 2)
EQA for quality and quantity of cfDNA extracted from plasma. There are two rounds of EQA per year which need to be purchased separately. This EQA will be distributed in Sept 2026.